|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Deciphera Pharmaceuticals Inc. (DCPH)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-06-19 Sale |
2019-06-21 4:03 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
177 | $25 | $4,425 | 149,258 (Direct) |
View |
| 2019-06-03 Sale |
2019-06-05 4:08 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
2,100 | $25.2 | $52,927 | 149,435 (Direct) |
View |
| 2019-05-21 Sale |
2019-05-23 4:04 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
1,473 | $25.06 | $36,919 | 151,635 (Direct) |
View |
| 2019-05-01 Sale |
2019-05-03 4:07 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
13,500 | $22.93 | $309,524 | 153,008 (Direct) |
View |
| 2019-02-19 Sale |
2019-02-20 8:37 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
1,500 | $30 | $45,000 | 166,508 (Direct) |
View |
| 2019-02-14 Sale |
2019-02-19 7:25 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
18,883 | $28.04 | $529,446 | 131,190 (Direct) |
View |
| 2019-02-14 Sale |
2019-02-19 7:24 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
9,431 | $28.85 | $272,106 | 548,566 (Direct) |
View |
| 2019-02-12 Sale |
2019-02-14 4:23 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
2,866 | $28 | $80,257 | 551,732 (Direct) |
View |
| 2019-02-12 Sale |
2019-02-14 4:22 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
3,522 | $28.01 | $98,637 | 135,213 (Direct) |
View |
| 2019-02-05 Sale |
2019-02-07 4:09 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
2,595 | $28.02 | $72,704 | 135,813 (Direct) |
View |
| 2019-02-05 Sale |
2019-02-07 4:04 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
1,700 | $28.01 | $47,611 | 551,932 (Direct) |
View |
| 2018-03-23 Sale |
2019-01-18 4:13 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
152,629 | $26 | $3,968,354 | 472,678 (Direct Indirect) |
View |
| 2019-01-11 Sale |
2019-01-15 5:00 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
300 | $26 | $7,800 | 625,307 (Indirect Direct) |
View |
| 2019-01-07 Sale |
2019-01-09 4:54 pm |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
5,000 | $25.18 | $125,900 | 168,008 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-07-08 Option Award |
2019-07-08 6:31 pm |
N/A 2029-07-07 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director |
24,000 | $22.49 | 24,000 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:03 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
177 | $1.89 | 149,258 (Direct) |
View |
| 2019-06-19 Exercise |
2019-06-21 4:03 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
177 | $1.89 | 149,258 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 6:33 pm |
N/A 2029-06-11 |
Deciphera Pharmaceuticals Inc. | DCPH | Ross Michael Jay Director |
12,000 | $21.05 | 12,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 4:14 pm |
N/A 2029-06-11 |
Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director |
12,000 | $21.05 | 12,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 4:11 pm |
N/A 2029-06-11 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin John Richard Director |
12,000 | $21.05 | 12,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 4:11 pm |
N/A 2029-06-11 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
12,000 | $21.05 | 12,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 4:10 pm |
N/A 2029-06-11 |
Deciphera Pharmaceuticals Inc. | DCPH | Benz Edward J. JR Director |
12,000 | $21.05 | 12,000 (Direct) |
View |
| 2019-06-11 Option Award |
2019-06-13 4:10 pm |
N/A 2029-06-11 |
Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director |
12,000 | $21.05 | 12,000 (Direct) |
View |
| 2019-06-03 Exercise |
2019-06-05 4:08 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
2,100 | $1.89 | 149,435 (Direct) |
View |
| 2019-06-03 Exercise |
2019-06-05 4:08 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
2,100 | $1.89 | 149,435 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-23 4:04 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
1,373 | $1.89 | 151,635 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-23 4:04 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
100 | $1.89 | 151,635 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-23 4:04 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
1,373 | $1.89 | 151,635 (Direct) |
View |
| 2019-05-21 Exercise |
2019-05-23 4:04 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
100 | $1.89 | 151,635 (Direct) |
View |
| 2019-05-01 Exercise |
2019-05-03 4:07 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
13,500 | $1.89 | 153,008 (Direct) |
View |
| 2019-05-01 Exercise |
2019-05-03 4:07 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
13,500 | $1.89 | 153,008 (Direct) |
View |
| 2017-08-02 Gift |
2019-03-20 5:49 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
55,270 | $0 | 147,049 (Indirect) |
View |
| 2017-08-02 Gift |
2019-03-20 5:49 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
55,270 | $0 | 147,049 (Indirect) |
View |
| 2019-03-18 Option Award |
2019-03-20 5:47 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO |
22,000 | $0 | 400,000 (Direct) |
View |
| 2019-03-18 Option Award |
2019-03-20 5:47 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO |
30,000 | $0 | 400,000 (Direct) |
View |
| 2019-03-18 Option Award |
2019-03-20 5:47 pm |
N/A 2029-03-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO |
400,000 | $25.4 | 400,000 (Direct) |
View |
| 2019-02-21 Exercise |
2019-02-25 4:16 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
24,500 | $3.95 | 91,779 (Direct) |
View |
| 2019-02-21 Exercise |
2019-02-25 4:16 pm |
N/A 2026-09-26 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
24,500 | $3.95 | 91,779 (Direct) |
View |
| 2019-02-19 Exercise |
2019-02-20 8:37 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
1,500 | $1.89 | 166,508 (Direct) |
View |
| 2019-02-19 Exercise |
2019-02-20 8:37 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
1,500 | $1.89 | 166,508 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:25 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
1,101 | $1.89 | 131,190 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:25 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
17,782 | $1.89 | 131,190 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:25 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
1,101 | $1.89 | 131,190 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:25 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
17,782 | $1.89 | 131,190 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:24 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
500 | $1.89 | 548,566 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:24 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
4,934 | $1.89 | 548,566 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:24 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
3,997 | $1.89 | 548,566 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:24 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
500 | $1.89 | 548,566 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:24 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
4,934 | $1.89 | 548,566 (Direct) |
View |
| 2019-02-14 Exercise |
2019-02-19 7:24 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
3,997 | $1.89 | 548,566 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 4:23 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
200 | $1.89 | 551,732 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 4:23 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
2,666 | $1.89 | 551,732 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 4:23 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
200 | $1.89 | 551,732 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 4:23 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
2,666 | $1.89 | 551,732 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 4:22 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
600 | $1.89 | 135,213 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 4:22 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
2,922 | $1.89 | 135,213 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 4:22 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
600 | $1.89 | 135,213 (Direct) |
View |
| 2019-02-12 Exercise |
2019-02-14 4:22 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
2,922 | $1.89 | 135,213 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:09 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
2,595 | $1.89 | 135,813 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:09 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director |
2,595 | $1.89 | 135,813 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:04 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
1,700 | $1.89 | 551,932 (Direct) |
View |
| 2019-02-05 Exercise |
2019-02-07 4:04 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
1,700 | $1.89 | 551,932 (Direct) |
View |
| 2019-01-30 Option Award |
2019-02-01 4:21 pm |
N/A 2029-01-29 |
Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas CEO |
263,000 | $26.35 | 263,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-02-01 4:19 pm |
N/A 2029-01-29 |
Deciphera Pharmaceuticals Inc. | DCPH | Ruddy Stephen B. CTO |
52,000 | $26.35 | 52,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-02-01 4:18 pm |
N/A 2029-01-29 |
Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer |
52,000 | $26.35 | 52,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-02-01 4:17 pm |
N/A 2029-01-29 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
52,000 | $26.35 | 52,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-02-01 4:14 pm |
N/A 2029-01-29 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
75,000 | $26.35 | 75,000 (Direct) |
View |
| 2019-01-30 Option Award |
2019-02-01 4:13 pm |
N/A 2029-01-29 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
75,000 | $26.35 | 75,000 (Direct) |
View |
| 2018-03-23 Gift |
2019-01-18 4:13 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
91,779 | $0 | 472,678 (Indirect) |
View |
| 2018-03-23 Gift |
2019-01-18 4:13 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
91,779 | $0 | 472,678 (Indirect) |
View |
| 2018-03-23 Exercise |
2019-01-18 4:13 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
152,629 | $1.89 | 472,678 (Direct) |
View |
| 2018-03-23 Exercise |
2019-01-18 4:13 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
152,629 | $1.89 | 472,678 (Direct) |
View |
| 2019-01-11 Exercise |
2019-01-15 5:00 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
300 | $1.89 | 625,307 (Direct) |
View |
| 2019-01-11 Exercise |
2019-01-15 5:00 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
300 | $1.89 | 625,307 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:54 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
5,000 | $1.89 | 168,008 (Direct) |
View |
| 2019-01-07 Exercise |
2019-01-09 4:54 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO |
5,000 | $1.89 | 168,008 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:20 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
36,746 | $1.89 | 207,614 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:20 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
207,614 | $1.89 | 207,614 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:20 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
8,166 | $1.89 | 207,614 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:20 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
46,137 | $1.89 | 207,614 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:20 pm |
N/A 2026-09-26 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
8,500 | $3.95 | 207,614 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:20 pm |
N/A 2026-09-26 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
48,025 | $3.95 | 207,614 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:20 pm |
N/A 2027-06-03 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
8,121 | $6.13 | 207,614 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:20 pm |
N/A 2027-06-03 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
45,883 | $6.13 | 207,614 (Direct) |
View |
| 2017-10-02 Option Award |
2018-09-20 4:20 pm |
N/A 2028-02-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Rosen Oliver Chief Medical Officer |
68,500 | $29.71 | 207,614 (Direct) |
View |
| 2017-10-02 Conversion |
2018-09-20 4:19 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
147,049 | $0 | 625,607 (Indirect) |
View |
| 2017-10-02 Conversion |
2018-09-20 4:19 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
22,070 | $0 | 625,607 (Indirect) |
View |
| 2017-10-02 Conversion |
2018-09-20 4:19 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,494 | $0 | 625,607 (Indirect) |
View |
| 2017-10-02 Conversion |
2018-09-20 4:19 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,392 | $0 | 625,607 (Indirect) |
View |
| 2017-10-02 Conversion |
2018-09-20 4:19 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
1,071 | $0 | 625,607 (Indirect) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:19 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
110,727 | $1.89 | 625,607 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:19 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
625,607 | $1.89 | 625,607 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:19 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
24,607 | $1.89 | 625,607 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:19 pm |
N/A 2025-12-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
139,029 | $1.89 | 625,607 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:19 pm |
N/A 2026-09-26 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
7,000 | $3.95 | 625,607 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:19 pm |
N/A 2026-09-26 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
39,550 | $3.95 | 625,607 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:19 pm |
N/A 2027-06-03 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
26,835 | $6.13 | 625,607 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:19 pm |
N/A 2027-06-03 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
151,617 | $6.13 | 625,607 (Direct) |
View |
| 2017-10-02 Option Award |
2018-09-20 4:19 pm |
N/A 2028-02-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer |
68,500 | $29.71 | 625,607 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:18 pm |
N/A 2026-10-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer |
42,575 | $3.95 | 240,548 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:18 pm |
N/A 2026-10-20 |
Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer |
240,548 | $3.95 | 240,548 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:18 pm |
N/A 2027-06-03 |
Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer |
3,590 | $6.13 | 240,548 (Direct) |
View |
| 2017-10-02 Exercise |
2018-09-20 4:18 pm |
N/A 2027-06-03 |
Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer |
20,283 | $6.13 | 240,548 (Direct) |
View |
| 2017-10-02 Option Award |
2018-09-20 4:18 pm |
N/A 2028-02-15 |
Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer |
60,000 | $29.71 | 240,548 (Direct) |
View |
| 2018-05-29 Option Award |
2018-09-20 4:18 pm |
N/A 2028-05-28 |
Deciphera Pharmaceuticals Inc. | DCPH | Ruddy Stephen B. CTO |
90,000 | $26.5 | 90,000 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 4:17 pm |
N/A N/A |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
20,000 | $0 | 90,000 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 4:17 pm |
N/A 2028-09-17 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer |
90,000 | $36.1 | 90,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:27 pm |
N/A 2028-05-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Ross Michael Jay Director |
12,000 | $25.73 | 12,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:25 pm |
N/A 2028-05-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Ratcliffe Liam Director, 10% Owner |
12,000 | $25.73 | 12,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:24 pm |
N/A 2028-05-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. Director |
24,000 | $25.73 | 24,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:23 pm |
N/A 2028-05-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director |
12,000 | $25.73 | 12,000 (Direct) |
View |
| 2018-05-17 Option Award |
2018-05-21 4:23 pm |
N/A 2028-05-16 |
Deciphera Pharmaceuticals Inc. | DCPH | Martin John Richard Director |
12,000 | $25.73 | 12,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 17 Jul 2019 23:47:10 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |